يعرض 1 - 10 نتائج من 38 نتيجة بحث عن '"kidney injury/et [Etiology]"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: interleukin 6/ec [Endogenous Compound], nitrogen/ec [Endogenous Compound], animal cell, animal experiment, animal model, article, bone marrow cell, C57BL 6 mouse, cell infiltration, controlled study, creatinine blood level, disease severity, gene deletion, histology, immunohistochemistry, kidney function, kidney injury/dt [Drug Therapy], kidney injury/et [Etiology], kidney injury/pc [Prevention], kidney ischemia/dt [Drug Therapy], kidney ischemia/et [Etiology], kidney ischemia/pc [Prevention], kidney tubule disorder/et [Etiology], kidney tubule necrosis/dt [Drug Therapy], kidney tubule necrosis/et [Etiology], macrophage, male, mouse, neutrophil chemotaxis, nonhuman, priority journal, real time polymerase chain reaction, renal protection, reperfusion injury/dt [Drug Therapy], reperfusion injury/et [Etiology], reperfusion injury/pc [Prevention], reverse transcription polymerase chain reaction, kidney injury molecule 1/ec [Endogenous Compound], protective agent/dv [Drug Development], protective agent/dt [Drug Therapy], protective agent/po [Oral Drug Administration], protective agent/pd [Pharmacology], protein kinase Syk/ec [Endogenous Compound], protein kinase Syk inhibitor/dv [Drug Development], protein kinase Syk inhibitor/dt [Drug Therapy], protein kinase Syk inhibitor/po [Oral Drug Administration], protein kinase Syk inhibitor/pd [Pharmacology], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, urea/ec [Endogenous Compound], cc 0417/dv [Drug Development], cc 0417/dt [Drug Therapy], cc 0417/po [Oral Drug Administration], cc 0417/pd [Pharmacology], animal tissue, severe renal impairment/et [Etiology], signal transduction, thrombocyte activation, thrombocyte aggregation, macrophage elastase/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], upregulation, urea nitrogen blood level, CD68 antigen/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], cryopyrin/ec [Endogenous Compound], gelatinase B/ec [Endogenous Compound], heme oxygenase 1/ec [Endogenous Compound], inducible nitric oxide synthase/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39832Test
    American Journal of Pathology
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: interleukin 6/ec [Endogenous Compound], nitrogen/ec [Endogenous Compound], animal cell, animal experiment, animal model, article, bone marrow cell, C57BL 6 mouse, cell infiltration, controlled study, creatinine blood level, disease severity, gene deletion, histology, immunohistochemistry, kidney function, kidney injury/dt [Drug Therapy], kidney injury/et [Etiology], kidney injury/pc [Prevention], kidney ischemia/dt [Drug Therapy], kidney ischemia/et [Etiology], kidney ischemia/pc [Prevention], kidney tubule disorder/et [Etiology], kidney tubule necrosis/dt [Drug Therapy], kidney tubule necrosis/et [Etiology], macrophage, male, mouse, neutrophil chemotaxis, nonhuman, priority journal, real time polymerase chain reaction, renal protection, reperfusion injury/dt [Drug Therapy], reperfusion injury/et [Etiology], reperfusion injury/pc [Prevention], reverse transcription polymerase chain reaction, kidney injury molecule 1/ec [Endogenous Compound], protective agent/dv [Drug Development], protective agent/dt [Drug Therapy], protective agent/po [Oral Drug Administration], protective agent/pd [Pharmacology], protein kinase Syk/ec [Endogenous Compound], protein kinase Syk inhibitor/dv [Drug Development], protein kinase Syk inhibitor/dt [Drug Therapy], protein kinase Syk inhibitor/po [Oral Drug Administration], protein kinase Syk inhibitor/pd [Pharmacology], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, urea/ec [Endogenous Compound], cc 0417/dv [Drug Development], cc 0417/dt [Drug Therapy], cc 0417/po [Oral Drug Administration], cc 0417/pd [Pharmacology], animal tissue, severe renal impairment/et [Etiology], signal transduction, thrombocyte activation, thrombocyte aggregation, macrophage elastase/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], upregulation, urea nitrogen blood level, CD68 antigen/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], cryopyrin/ec [Endogenous Compound], gelatinase B/ec [Endogenous Compound], heme oxygenase 1/ec [Endogenous Compound], inducible nitric oxide synthase/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], Article

  3. 3
  4. 4
    مورد إلكتروني
  5. 5
    مورد إلكتروني
  6. 6
    مورد إلكتروني
  7. 7
  8. 8
    مورد إلكتروني
  9. 9
  10. 10
    مورد إلكتروني